Development of a patient decision aid for superficial basal-cell carcinoma.

Patients with superficial basal-cell carcinomas (sBCC) may be offered several treatment options including surgery, imiquimod, 5-fluorouracil (5FU), or photodynamic therapy (PDT). (1, 2) Patient decision aids (PDA) are tools to assist patients and physicians in shared decision making; a recent study showed that patients with BCC would like to participate in decision making. (3) Stacey et al. provided evidence showing that PDAs helped patients improve knowledge of their disease, possible treatments and risk-assessment. (4) Junn et al. recently described the development of a paper-based PDA for patients with sBCC with limited life expectancy that weighs benefits and risks of treatments versus watchful waiting. (5) We describe the development of a digital PDA for all patients with sBCC. The PDA was developed in line with the International Patient Decision Aid Standards (IPDAS). (6).